|
Q3 2017
Filed on Nov 14, 2017
|
36,314
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
740,262
|
N/A
|
|
Nord Anglia Education Inc
|
Q3 2017
Filed on Nov 14, 2017
|
768,587
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
1,040,992
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
14,819
|
$8.55 - $10.05
$127K - $149K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
43,515
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
494,685
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
50,403
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
4,752,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
16,238,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
592,618
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
291,475
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
77,661
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
281,831
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
149,239
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
2,728,831
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
77,867
|
$30.96 - $34.4
$2.41M - $2.68M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
17,644
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
587,961
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
1,351,984
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
18,707
|
$20.0 - $24.23
$374K - $453K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
8,917
|
$45.39 - $51.81
$405K - $462K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
713,054
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
66,580
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
48,000,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
42,567
|
N/A
|
|
Du Pont E I De Nemours & CO
|
Q3 2017
Filed on Nov 14, 2017
|
4,230,303
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
143,585
|
$49.68 - $59.46
$7.13M - $8.54M
|
|
Chicago Bridge & Iron CO N V
|
Q3 2017
Filed on Nov 14, 2017
|
23,983
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
120,281
|
$33.46 - $34.82
$4.02M - $4.19M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
292,541
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
3,666
|
$80.62 - $86.05
$296K - $315K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
53,592
|
$31.66 - $37.16
$1.7M - $1.99M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
34,093
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
8,796
|
$36.95 - $43.85
$325K - $386K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
30,180
|
$102.94 - $110.92
$3.11M - $3.35M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
10,914
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
9,524
|
$21.53 - $26.3
$205K - $250K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
457,267
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
27,617
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
305,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
291,494
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
493,750
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
1,481,777
|
N/A
|
|
Valeant Pharmaceuticals Intl
|
Q3 2017
Filed on Nov 14, 2017
|
186,346
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
33,023,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
51,755
|
$210.25 - $271.0
$10.9M - $14M
|
|